https://doi.org/10.1038/onc.2014.286
M
Massimo Fantini
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
94
Papers
3.8K
Citations
26
h-index
43
i10-index
Massimo Fantini is an academic researcher from Precision BioLogic (Canada). The author has contributed to research in topics: Monoclonal and Polyclonal Antibodies Research & Glycosylation and Glycoproteins Research & Immunotherapy and Immune Responses. The author has an h-index of 26, co-authored 80 publications.
ORCID: 0000-0002-8164-2587Papers by this author
worksTh17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth
2014 · Oncogene · 585 citations
<i>In vitro</i>and<i>in vivo</i>inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors
2016 · Oncotarget · 111 citations
https://doi.org/10.18632/oncotarget.7062
Curcumin induces apoptosis in breast cancer cell lines and delays the growth of mammary tumors in neu transgenic mice.
2013 · PubMed · 64 citations
Smad7 knockdown activates protein kinase RNA-associated eIF2α pathway leading to colon cancer cell death
2017 · Cell Death and Disease · 26 citations
https://doi.org/10.1038/cddis.2017.103
An IL-15 Superagonist, ALT-803, Enhances Antibody-Dependent Cell-Mediated Cytotoxicity Elicited by the Monoclonal Antibody NEO-201 Against Human Carcinoma Cells
2019 · Cancer Biotherapy and Radiopharmaceuticals · 26 citations
https://doi.org/10.1089/cbr.2018.2628
Natural humoral immune response to ribosomal P0 protein in colorectal cancer patients
2015 · Journal of Translational Medicine · 21 citations
https://doi.org/10.1186/s12967-015-0455-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat